Auro Laboratories Limited (BOM:530233)
277.50
+5.20 (1.91%)
At close: May 29, 2026
Auro Laboratories Revenue
In the fiscal year ending March 31, 2026, Auro Laboratories had annual revenue of 327.49M INR with 68.82% growth. Auro Laboratories had revenue of 104.96M in the quarter ending March 31, 2026, with 39.20% growth.
Revenue
327.49M
Revenue Growth
+68.82%
P/S Ratio
5.28
Revenue / Employee
4.55M
Employees
72
Market Cap
1.73B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2026 | 327.49M | 133.51M | 68.82% |
| Mar 31, 2025 | 193.98M | -342.37M | -63.83% |
| Mar 31, 2024 | 536.35M | 7.41M | 1.40% |
| Mar 31, 2023 | 528.94M | 20.28M | 3.99% |
| Mar 31, 2022 | 508.66M | -33.86M | -6.24% |
| Mar 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Aarey Drugs & Pharmaceuticals | 4.78B |
| Influx Healthtech | 1.47B |
| Kimia Biosciences | 1.17B |
| Panchsheel Organics | 1.10B |
| Smruthi Organics | 1.02B |
| Resonance Specialties | 918.89M |
| Tyche Industries | 628.56M |
| Vasundhara Rasayans | 386.27M |
Auro Laboratories News
- 1 year ago - Shaan Jain resigns as CFO of Auro Laboratories, effective December 18, 2024 - Business Upturn